Merial, a major player in the animal health sector, has gained full-licensure from the U.S. Department of Agriculture for ONCEPT(TM) Canine Melanoma Vaccine, DNA. ONCEPT is a breakthrough vaccine indicated for aiding in extending survival of dogs with stage II or stage III oral canine melanoma, a common yet deadly form of cancer in dogs.
ONCEPT is the first and only USDA-approved, therapeutic vaccine for the treatment of cancer – in either animals or humans.
- Major Canine Cancer Breakthrough
- Children Give Up Birthday Gifts in Battle Against Canine Cancer
- New Cancer Treatment Centre Could Help Thousands of Dogs
Enter your email address below and never miss out on the latest, most important dog news: